Snowdon Pharmaceuticals, Inc.

Monmouth Junction, NJ 08852

SBIR Award Summary

Total Number of Awards 4
Total Value of Awards $884K
First Award Date 01/22/08
Most Recent Award Date 09/01/10

Key Personnel

Last Name Name Awards Contact
Wood Richard D Wood 2
Ekins Sean Ekins 2

4 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-134
Budget: 09/01/10 - 02/29/12

DESCRIPTION (provided by applicant): Toxoplasma (T.) gondii, the causative agent of toxoplasmosis, is a ubiquitous opportunistic pathogen that infects both immune-competent and immune-compromised individuals worldwide, and is the leading cause of severe congenital neurological and ocular disease in humans. Toxoplasmosis is also a major opportuni...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-134
Budget: 09/04/09 - 08/31/10

DESCRIPTION (provided by applicant): Toxoplasma (T.) gondii, the causative agent of toxoplasmosis, is a ubiquitous opportunistic pathogen that infects both immune-competent and immune-compromised individuals worldwide, and is the leading cause of severe congenital neurological and ocular disease in humans. Toxoplasmosis is also a major opportuni...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-07-80
Budget: 05/01/08 - 10/31/10

DESCRIPTION (provided by applicant): Tubulin binding compounds that interfere with the dynamic stability of microtubules and disrupt the formation of the mitotic spindle are widely considered one of the most desirable classes of anti-cancer agents. Unfortunately virtually all clinically available tubulin binding agents used for human cancer ther...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-07-80
Budget: 01/22/08 - 12/31/09

DESCRIPTION (provided by applicant): This SBIR Phase I feasibility study aims to implement a novel strategy for the development aggregation inhibitors as treatments for Alzheimer's Disease (AD), Parkinson's Disease (PD), and potentially other amyloid and protein misfolding diseases. Amyloid diseases are characterized by transformation of protein...